QPharma revamps its commercialization/compliance IT suite as Titanium

QPharma (Morristown, NJ) has been offering a software suite branded as Python for a number of years; now it has been rebranded as Titanium and upgraded with new features and capabilities, according to the firm. Titanium enables pharma and med device companies to manage sample distribution in compliance with the Prescription Drug Marketing Act (PDMA), to provide sales-rep training, and to maintain compliance with the Physician Payments Sunshine Act.

Titanium now includes tools and dashboards to help pharmaceutical companies manage their sample accountability; a module to give home office personnel key insights into direct-to-practitioner sampling activities; a module for identifying, profiling, and engaging Key Opinion Leaders (KOLs), among other applications.

“We look forward to working closely with our valued clients to introduce them to the new and upcoming system features,” added Ed Sleeper, VP of Commercial Solutions at QPharma. “Titanium is more than just a facelift to the software suite formerly known as Python — it’s a series of system-wide enhancements that will make the platform more intuitive, increase our reporting and dashboard functionality, and make the integrations between our commercial and compliance modules more efficient.”

In addition to Titanium, QPharma provides software validation services, training and alternative sampling capabilities. In January, it acquired Qforma, a company specializing in KOL and related business intelligence analysis.